Novel coronavirus (SARS-CoV-2) infection in a patient with multivisceral transplant

Rodrigo Papa-Gobbi,Alba Bueno,Javier Serradilla,Paloma Talayero,Pablo Stringa,Barbara Pascual-Miguel, Alida Alcolea-Sanchez,Rocio Gonzalez-Sacristan,Ane M. Andres,Manuel Lopez-Santamaria,Martin Rumbo,Esther Ramos-Boluda,Francisco Hernandez-Oliveros

Transplant Infectious Disease（2021）

引用 4|浏览6

暂无评分

摘要

Coronavirus disease 2019 (COVID-19) pandemic has become one of the most challenging episodes in the history of modern public health, with particular emphasis in high risk population. However, the evidence regarding their response to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2), the agent responsible for COVID-19 is scant . Herein we present the clinical and therapeutic course of a SARS-CoV-2 infection in a patient with multivisceral transplant and a recent tuberculosis infection.

查看译文

关键词

COVID-19,SARS-CoV-19,clinical research/practice,coronavirus,immunosuppression,infection and infectious agents-viral,multivisceral transplant,small bowel,visceral transplant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要